ArticleHuman vaccines & immunotherapeutics2021

Cost-effectiveness analysis of replacing the 10-valent pneumococcal conjugate vaccine (PCV10) with the 13-valent pneumococcal conjugate vaccine (PCV13) in Brazil infants.

Johnna Perdrizet et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.